LBA2_PROverall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Analyses from PALOMA-3. (23rd October 2018) - Cristofanilli, M; Slamon, D J; Ro, J; Bondarenko, I; Im, S-A; Masuda, N; Colleoni, M; DeMichele, A; Loi, S; Verma, S; Iwata, H; Harbeck, N; et al.